Credo Technology Group Holding Ltd financials

SEC pipeline catching up: most recent reported quarter (2026-04-30) isn't incorporated yet — this page is anchored to 2026-01-31 (Q3 2026 · 10-Q). New filings land within a few weekday pipeline runs.
CRDO CIK 0001807794

Source: EDGAR filings · Built 2026-06-03T02:25:27Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2022FY 2022
Free Cash Flow 29.02M 17.09M -46.33M -48.41M -48.42M -19.09M
EBITDA 59.06M -23.29M -11.72M -17.18M -23.02M 3.88M
Working Capital 605.82M 485.64M 297.20M 305.68M 125.27M
Net Debt -220.29M -53.07M -93.08M -242.13M -103.76M
Gross Margin 64.77% 61.89% 57.65% 60.12% 65.21% 85.64%
Operating Margin 8.50% -19.20% -11.53% -20.63% -42.99% 3.85%
Net Margin 11.95% -14.70% -8.98% -20.83% -46.87% 2.47%
Return on Equity (ROE) 7.66% -5.25% -4.76% -6.64% 49.63% -14.13%
Return on Assets (ROA) 6.45% -4.71% -4.17% -5.90% -17.69%
Current Ratio 6.62× 11.88× 10.58× 12.54× 11.00×
Debt-to-Equity 0.02× 0.03× 0.04× 0.05× 0.00×
Effective Tax Rate 4.90% -24.73% 7.63% 0.17% -8.76% 36.56%
Cash Conversion Ratio 1.25× -1.15× 1.49× 1.39× 1.54× -7.71×
Accruals Ratio -0.02× -0.10× 0.02× 0.02× 0.10×
SBC % of Revenue 17.71% 20.22% 12.77% 8.63% 4.38% 2.32%
CapEx Coverage 1.80× 2.09× -1.13× -1.75× -6.99× -1.16×
Free Cash Flow Per Share $0.16 $0.11 $-0.32 $-0.55 $-0.70 $-0.27

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2022FY 2022
P/E Trailing (Diluted) 166.41×
P/FCF 301.25× 168.42×
FCF Yield 0.33% 0.59%
EV / EBITDA 136.13×
P/S 18.91× 15.80× 6.55× 15.01×
P/B 12.12× 5.65× 3.47× 4.78×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2022FY 2022
Revenue from Contract with Customer, Excluding Assessed Tax 436.77M 192.97M 184.19M 106.48M 58.70M 53.84M
Cost of Goods and Services Sold 153.87M 73.54M 78.00M 42.46M 20.42M 7.73M
Gross Profit 282.91M 119.43M 106.19M 64.02M 38.28M 46.11M
Research and Development Expense 145.99M 95.53M 76.77M 47.95M 34.84M 27.56M
Selling, General and Administrative Expense 98.92M 60.19M 48.25M 34.90M 28.67M 16.47M
Operating Expenses 245.78M 156.49M 127.43M 85.98M 63.51M 44.03M
Operating Income (Loss) 37.12M -37.06M -21.23M -21.97M -25.23M 2.07M
Income Tax Expense (Benefit) 2.69M 5.62M -1.37M -37.00K 2.21M 766.00K
Net Income (Loss) Attributable to Parent 52.18M -28.37M -16.55M -22.18M -27.51M 1.33M
Earnings Per Share, Basic $0.31 $-0.18 $-0.11 $-0.25 $-0.40 $0.00
Weighted Average Number of Shares Outstanding, Basic 167.50M 155.09M 146.56M 88.40M 69.10M 71.73M
Earnings Per Share, Diluted $0.29 $-0.18 $-0.11 $-0.25 $-0.40 $0.00
Weighted Average Number of Shares Outstanding, Diluted 181.16M 155.09M 146.56M 88.40M 69.10M 71.73M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2022FY 2022
Cash and Cash Equivalents, at Carrying Value 236.33M 66.94M 108.58M 259.32M 103.76M
Assets, Current 713.53M 530.26M 328.23M 332.18M 137.80M
Assets 809.26M 601.93M 397.29M 375.69M 155.49M
Liabilities, Current 107.71M 44.62M 31.03M 26.50M 12.53M
Liabilities 127.67M 61.73M 49.65M 41.53M 12.96M
Stockholders' Equity Attributable to Parent 681.58M 540.20M 347.63M 334.16M -55.43M -9.41M
Common Stock, Shares, Outstanding 171.17M 164.31M 148.65M 144.75M 68.28M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2022FY 2022
Net Cash Provided by (Used in) Operating Activities 65.08M 32.74M -24.61M -30.83M -42.36M -10.25M
Payments to Acquire Property, Plant, and Equipment 36.06M 15.65M 21.71M 17.58M 6.06M 8.83M
Net Cash Provided by (Used in) Investing Activities 111.99M -249.49M -130.94M -17.58M -6.06M -8.83M
Payments for Repurchase of Common Stock 0 0 22.91M 0
Net Cash Provided by (Used in) Financing Activities -7.73M 175.28M 4.88M 204.18M 77.89M 61.21M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CRDO CIK 0001807794), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RNTX

REIN THERAPEUTICS, INC.

BAER

BRIDGER AEROSPACE GROUP HOLDINGS, INC.

HUMA

Humacyte, Inc.